Synonyms: 3',5'-Monophosphate, Adenosine Cyclic; Adenosine Cyclic 3',5' Monophosphate; Cyclic AMP, Disodium Salt; Adenosine 3':5'-cyclic monophosphate; Adenosine 3,5'-cyclic monophosphorate; AKOS015999561; Tox21_113510_1; 3', 5'-cyclic adenosine monophosphate; adenosine 3',5'-(hydrogen phosphate); CCG-204179; DB02527; LP00084; Adenosine 3a(2),5a(2)-cyclophosphate; Cyclic AMP, Monoammonium Salt; NCGC00093588-01; NCGC00093588-02; NCGC00093588-04; NCGC00260769-01; AJ-46382; AJ-61692; AS-13112; H355; LS-15114; SC-09057; Cyclic AMP, Monopotassium Salt; AX8012006; ST2412623; Adenosine, 3',5'-cyclic-monophosphoric acid; CS-0013299; EU-0100084; FT-0624147; Adenosine 3',5'-cyclic monophosphate hydrate; Adenosine cyclic 3',5'-(hydrogen phosphate); ADENOSINE-3 ,5 -CYCLIC-MONOPHOSPHATE; A 9501; Cyclic AMP, Monosodium Salt; A-8685; C00575; 005C845; SR-01000075695; CYCLIC-3',5'-(HYDROGEN PHOSPHATE)ADENOSINE; SR-01000075695-1; 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, adenosine deriv.; Adenosine 3'',5''-cyclic phosphate (6CI); Cyclic 3'',5''-; B5C9F048-77DD-4170-A624-23C09E7B080D; Adenosine 3',5'-cyclic monophosphate, >=98.5% (HPLC), powder; Cyclic AMP, Sodium Salt; Adenosine-3 inverted exclamation mark ,5 inverted exclamation mark -cyclic phosphoric acid; (1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol; (2R,4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide; (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l;{5}-furo[3,2-d][1,3,2$l;{5}]dioxaphosphinin-2-one; (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l^{5}-furo[3,2-d][1,3,2$l^{5}]dioxaphosphinin-2-one; (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l^{5}-furo[3,2-d][1,3,2]dioxaphosphinin-2-one; (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide; (4aR,6R,7R,7aS)-6-(6-Aminopurin-9-yl)-2-oxo-tetrahydro-2-lambda*5*-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol; 4H-furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, (4aR,6R,7R,7aS)-; 6-(6-Amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide #; Cyclic Monophosphate, Adenosine; AMP, Cyclic; dimethylaminopyridine; Adenosine cyclic phosphate; Cyclic AMP, Sodium Salt; D03KYJ; D0UB2J; Cyclic AMP, (R)-Isomer; Cyclic AMP, Disodium Salt; Cyclic AMP, Monosodium Salt; >>.>> IUUOEa; Cyclic-3',5'-Monophosphate, Adenosine; Cyclic AMP, Monoammonium Salt; Cyclic Monophosphate, Adenosine; Monophosphate, Adenosine Cyclic; Cyclic AMP, Monopotassium Salt; CID6076; adenosin-3',5'-phosphatmonohydrat; Adenosine Cyclic 3,5 Monophosphate; NSC94017; C10-H12-N5-O6-P; adenosine cyclic-3',5'-monophosphate; Monophosphate, Adenosine Cyclic; Adenosine Cyclic 3',5' Monophosphate; 3',5'-Monophosphate, Adenosine Cyclic; Cyclic 3',5'-Monophosphate, Adenosine; Cyclic-3',5'-Monophosphate, Adenosine; Adenosine 3',5'-cyclophosphate, 99% - 1G 1g; D000242; CMP; 114697-05-1; 85187-54-8; cAMP; Cyclic AMP; Adenosine Cyclic 3',5'-Monophosphate; 60-92-4; Adenosine 3',5'-cyclic monophosphate; 3',5'-cyclic AMP; Adenosine 3',5'-phosphate; Adenosine 3',5'-cyclophosphate; cyclic 3',5'-AMP; Adenosine cyclic monophosphate; cyclic 3',5'-Adenylic acid; Adenosine 3',5'-monophosphate; Adenosine-3',5'-cyclophosphate; Adenosine Cyclic 3,5 Monophosphate; cyclic Adenosine 3',5'-phosphate; Cyclic Adenosine Monophosphate; Cyclic adenylic acid; Adenosine cyclic 3',5'-monophosphate; 3',5'-AMP; cyclic Adenosine 3',5'-monophosphate; Adenosine cyclic 3',5'-phosphate; adenosine-3',5'-cyclic-monophosphate; CCRIS 4291; Adenosine, cyclic 3',5'-(hydrogen phosphate); Adenosine Cyclic Monophosphate; Adenosine cyclophosphate; [3H]cAMP; Adenosine 3',5'-cyclic phosphate; [3H]-cAMP; UNII-E0399OZS9N; NSC 94017; Acrasin; Adenosine 3',5'-phosphate monohydrate; BRN 0052645; CHEBI:17489; Adenosine Cyclic-3',5'-Monophosphate; Adenosine cyclicphosphate; EINECS 200-492-9; CHEMBL316966; E0399OZS9N; IVOMOUWHDPKRLL-KQYNXXCUSA-N; MFCD00005845; NCGC00093588-03; Adenosine 3,5'-cyclic monophosphoric acid; DSSTox_CID_20436; DSSTox_RID_79492; AMP, Cyclic; DSSTox_GSID_40436; adenosine-cyclic-phosphate; 3',5'-cAMP; adenosine cyclic-monophosphate; adenosine-cyclic-phosphoric-acid; (4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol; Adenosine 3',5'-cyclic monophosphate, 99+%; adenosine-3',5'-cyclic monophosphate; Adenosine-3',5'-cyclic phosphate; C10H12N5O6P; Cyclic 3',5'-Monophosphate, Adenosine; Adenosine 3'-,5'-cyclic monophosphate; CAS-60-92-4; 6-(6-Amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide; AK-93426; IUUO>>.AxEao yen; 3'5'-cyclic AMP; CYCLIC AMP; CAMP; Cyclic 3',5'-adenylate; bmse000071; Epitope ID:137352; Cyclic AMP; AC1L1LR0; SCHEMBL1244; Adenosini Cycloghosghas,(S); Lopac0_000084; 4-26-00-03618 (Beilstein Handbook Reference); 3' 5'-adenosine monophosphate; GTPL2352; GTPL5096; cAMP; 3',5'-Cyclic AMP; DTXSID8040436; Cyclic AMP, (R)-Isomer; BDBM10851; cid_23902375; HMS3260A10; HY-B1511; ZINC3873977; Tox21_113510; Tox21_500084; Adenosine-3',5'-cyclicmonophosphate; BDBM50384264; Adenosine 3',5'-cyclophosphoric acid;